帕博利珠单抗诱导的脱髓鞘性多发性神经根神经病 - Suppr

Suppr

超能文献

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

作者信息

de Maleissye Marie-Florence, Nicolas Guillaume, Saiag Philippe

机构信息

Université Versailles Saint-Quentin-en-Yvelines, Versailles, France

出版信息

N Engl J Med. 2016 Jul 21;375(3):296-7. doi: 10.1056/NEJMc1515584.

DOI:10.1056/NEJMc1515584

PMID:27468083

Abstract

摘要

相似文献

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

N Engl J Med. 2016 Jul 21;375(3):296-7. doi: 10.1056/NEJMc1515584.

Chronic polyradiculoneuropathy associated with pembrolizumab for bladder cancer.

Acta Neurol Belg. 2024 Jun;124(3):1063-1065. doi: 10.1007/s13760-023-02439-z. Epub 2023 Nov 27.

Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient.

Neurol India. 2018 Mar-Apr;66(2):509-511. doi: 10.4103/0028-3886.227311.

Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report.

Can J Ophthalmol. 2016 Feb;51(1):e4-6. doi: 10.1016/j.jcjo.2015.09.008.

Pembrolizumab for melanoma- safety profile and future trends.

Expert Opin Drug Saf. 2016 Jun;15(6):727-9. doi: 10.1080/14740338.2016.1175430. Epub 2016 Apr 27.

Chronic inflammatory demyelinating polyneuropathy after commencement of dupilumab for atopic dermatitis: Coincidence or contributory?

Ann Allergy Asthma Immunol. 2022 Jan;128(1):105-106. doi: 10.1016/j.anai.2021.08.415. Epub 2021 Sep 1.

A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma.

Muscle Nerve. 2017 Jun;55(6):E25-E26. doi: 10.1002/mus.25496. Epub 2017 Mar 23.

Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma.

Ann Oncol. 2000 Sep;11(9):1197-200. doi: 10.1023/a:1008362714023.

Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.

J Immunother. 2015 Jan;38(1):37-9. doi: 10.1097/CJI.0000000000000060.

Could knee inflammatory synovitis be induced by pembrolizumab?

J Oncol Pharm Pract. 2018 Jul;24(5):389-392. doi: 10.1177/1078155217701292. Epub 2017 Mar 29.

引用本文的文献

Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.

Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report.

World J Clin Oncol. 2025 Feb 24;16(2):97823. doi: 10.5306/wjco.v16.i2.97823.

Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients.

J Neurol. 2024 Oct;271(10):6514-6525. doi: 10.1007/s00415-024-12660-2. Epub 2024 Sep 3.

Case report and brief literature review: possible association of secukinumab with Guillain-Barré syndrome in psoriasis.

Front Immunol. 2024 Jun 28;15:1412470. doi: 10.3389/fimmu.2024.1412470. eCollection 2024.

A Case of Pembrolizumab-Induced Myasthenia Gravis.

Cureus. 2023 Sep 18;15(9):e45455. doi: 10.7759/cureus.45455. eCollection 2023 Sep.

Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors.

Medicina (Kaunas). 2023 May 23;59(6):1003. doi: 10.3390/medicina59061003.

Diagnostics (Basel). 2022 Aug 29;12(9):2091. doi: 10.3390/diagnostics12092091.

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy.

Cureus. 2022 Jul 21;14(7):e27112. doi: 10.7759/cureus.27112. eCollection 2022 Jul.

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.

Curr Neuropharmacol. 2022;20(6):1229-1240. doi: 10.2174/1570159X20666211223130228.

Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.

Cancer Immunol Immunother. 2022 Apr;71(4):769-775. doi: 10.1007/s00262-021-03053-9. Epub 2021 Sep 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

作者信息

de Maleissye Marie-Florence, Nicolas Guillaume, Saiag Philippe

机构信息

Université Versailles Saint-Quentin-en-Yvelines, Versailles, France

出版信息

N Engl J Med. 2016 Jul 21;375(3):296-7. doi: 10.1056/NEJMc1515584.

DOI:10.1056/NEJMc1515584

PMID:27468083

Abstract

摘要

相似文献

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

N Engl J Med. 2016 Jul 21;375(3):296-7. doi: 10.1056/NEJMc1515584.

Chronic polyradiculoneuropathy associated with pembrolizumab for bladder cancer.

Acta Neurol Belg. 2024 Jun;124(3):1063-1065. doi: 10.1007/s13760-023-02439-z. Epub 2023 Nov 27.

Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient.

Neurol India. 2018 Mar-Apr;66(2):509-511. doi: 10.4103/0028-3886.227311.

Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report.

Can J Ophthalmol. 2016 Feb;51(1):e4-6. doi: 10.1016/j.jcjo.2015.09.008.

Pembrolizumab for melanoma- safety profile and future trends.

Expert Opin Drug Saf. 2016 Jun;15(6):727-9. doi: 10.1080/14740338.2016.1175430. Epub 2016 Apr 27.

Chronic inflammatory demyelinating polyneuropathy after commencement of dupilumab for atopic dermatitis: Coincidence or contributory?

Ann Allergy Asthma Immunol. 2022 Jan;128(1):105-106. doi: 10.1016/j.anai.2021.08.415. Epub 2021 Sep 1.

A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma.

Muscle Nerve. 2017 Jun;55(6):E25-E26. doi: 10.1002/mus.25496. Epub 2017 Mar 23.

Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma.

Ann Oncol. 2000 Sep;11(9):1197-200. doi: 10.1023/a:1008362714023.

Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.

J Immunother. 2015 Jan;38(1):37-9. doi: 10.1097/CJI.0000000000000060.

Could knee inflammatory synovitis be induced by pembrolizumab?

J Oncol Pharm Pract. 2018 Jul;24(5):389-392. doi: 10.1177/1078155217701292. Epub 2017 Mar 29.

引用本文的文献

Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.

Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.

Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report.

World J Clin Oncol. 2025 Feb 24;16(2):97823. doi: 10.5306/wjco.v16.i2.97823.

Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients.

J Neurol. 2024 Oct;271(10):6514-6525. doi: 10.1007/s00415-024-12660-2. Epub 2024 Sep 3.

Case report and brief literature review: possible association of secukinumab with Guillain-Barré syndrome in psoriasis.

Front Immunol. 2024 Jun 28;15:1412470. doi: 10.3389/fimmu.2024.1412470. eCollection 2024.

A Case of Pembrolizumab-Induced Myasthenia Gravis.

Cureus. 2023 Sep 18;15(9):e45455. doi: 10.7759/cureus.45455. eCollection 2023 Sep.

Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors.

Medicina (Kaunas). 2023 May 23;59(6):1003. doi: 10.3390/medicina59061003.

Diagnostics (Basel). 2022 Aug 29;12(9):2091. doi: 10.3390/diagnostics12092091.

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy.

Cureus. 2022 Jul 21;14(7):e27112. doi: 10.7759/cureus.27112. eCollection 2022 Jul.

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.

Curr Neuropharmacol. 2022;20(6):1229-1240. doi: 10.2174/1570159X20666211223130228.

Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.

Cancer Immunol Immunother. 2022 Apr;71(4):769-775. doi: 10.1007/s00262-021-03053-9. Epub 2021 Sep 13.